The Department of Health and Human Services yesterday released initial data on how states and territories plan to use their share of 100 million rapid point-of-care tests for the COVID-19 virus, which the agency began distributing last month.

The initial data includes 32 states and the District of Columbia. The Food and Drug Administration in August authorized laboratories certified to perform moderate, high or waived complexity tests under the Clinical Laboratory Improvement Amendment to use the Abbot BinaxNOW antigen test to detect SARS-CoV-2 in nasal swabs from individuals whose health care provider suspects they have COVID-19 within seven days of symptom onset.

Related News Articles

Headline
The Centers for Disease Control and Prevention today announced shorter quarantine options based on local circumstances and resources, for people exposed to the…
Headline
The AHA today launched a new periodic report to convey to congressional staff hospitals’ and health systems’ desperate need for a new COVID-19 relief package…
Headline
Reps. Bradley Schneider, D-Ill., and David McKinley, R-W.Va., today introduced the Medicare Sequester COVID Moratorium Act, AHA-supported legislation that…
Headline
An independent advisory group for the Centers for Disease Control and Prevention yesterday recommended health care personnel and long-term care facility…
Headline
The Department of Health and Human Services should provide greater flexibility around health care staffing, provider resource allocation and accessibility to…
Headline
The Senate Homeland Security and Governmental Affairs Committee today held a hearing on defending communities from cyber threats during the COVID-19 pandemic…